Abeona Therapeutics Inc. (ABEO)

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company that focuses on developing and delivering gene and cell therapies for rare genetic diseases. Founded in 1974, the company is particularly committed to addressing conditions with significant unmet medical needs. As of the latest update, Dr. Vish Seshadri serves as Abeona's Chief Executive Officer. Abeona is working on several promising therapies, including those for epidermolysis bullosa and Sanfilippo syndrome. While their revenue is not substantial yet due to their clinical-stage status, the promising nature of their research has made them a noteworthy player in the biotech industry. With its headquarters in New York City, Abeona is deeply invested in advancing science and improving the lives of patients with rare diseases.